Why the study?
Are HDL-C and HDL-P levels associated with carotid intima-media thickness and carotid plaque in postmenopausal women?
Are HDL-C and HDL-P levels associated with carotid intima-media thickness and carotid plaque in postmenopausal women?
In postmenopausal women, higher HDL particle concentration (HDL-P) is associated with lower cIMT, whereas higher HDL-C is paradoxically associated with greater risk of carotid plaque, suggesting HDL-C may not always be cardioprotective.
Answers are grounded in this paper and cite their sources.
HDL metrics may warrant menopause-specific evaluation for vascular risk in women; leaves open causality and clinical utility.
Objective- HDL-C (high-density lipoprotein cholesterol) may not always be cardioprotective in postmenopausal women. HDL particles (HDL-P) via ion-mobility may better reflect the antiatherogenicity of HDL. Objectives were (1) to evaluate associations of HDL-C and ion-mobility HDL-P with carotid intima-media thickness (cIMT) and carotid plaque separately and jointly in women; and (2) to assess interactions by age at and time since menopause. Approach and Results- Analysis included 1380 females from the MESA (Multi-Ethnic Study of Atherosclerosis; age: 61.8±10.3; 61% natural-, 21% surgical-, and 18% peri-menopause). Women with unknown or early menopause (age at nonsurgical menopause ≤45 years) were excluded. Adjusting for each other, higher HDL-P but not HDL-C was associated with lower cIMT ( P=0.001), whereas higher HDL-C but not HDL-P was associated with greater risk of carotid plaque presence ( P=0.04). Time since menopause significantly modified the association of large but not small HDL-P with cIMT; higher large HDL-P was associated with higher cIMT close to menopause but with lower cIMT later in life. The proatherogenic association reported for HDL-C with carotid plaque was most evident in women with later age at menopause who were >10 years postmenopausal. Conclusions- Elevated HDL-C may not always be cardioprotective in postmenopausal women. The cardioprotective capacity of large HDL-P may adversely compromise close to menopause supporting the importance of assessing how the menopause transition might impact HDL quality and related cardiovascular disease risk later in life.
No takes yet. Share an insight, caveat, or question.
Khoudary et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: